Molecular Aspects Concerning the Use of the SARS-CoV-2 Receptor Binding Domain as a Target for Preventive Vaccines

[Image: see text] The development of recombinant COVID-19 vaccines has resulted from scientific progress made at an unprecedented speed during 2020. The recombinant spike glycoprotein monomer, its trimer, and its recombinant receptor-binding domain (RBD) induce a potent anti-RBD neutralizing antibod...

Descripción completa

Detalles Bibliográficos
Autores principales: Valdes-Balbin, Yury, Santana-Mederos, Darielys, Paquet, Françoise, Fernandez, Sonsire, Climent, Yanet, Chiodo, Fabrizio, Rodríguez, Laura, Sanchez Ramirez, Belinda, Leon, Kalet, Hernandez, Tays, Castellanos-Serra, Lila, Garrido, Raine, Chen, Guang-Wu, Garcia-Rivera, Dagmar, Rivera, Daniel G., Verez-Bencomo, Vicente
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084267/
https://www.ncbi.nlm.nih.gov/pubmed/34075345
http://dx.doi.org/10.1021/acscentsci.1c00216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084267/
https://www.ncbi.nlm.nih.gov/pubmed/34075345
http://dx.doi.org/10.1021/acscentsci.1c00216

Ejemplares similares